Package 10956-501-24

{"route": ["ORAL"], "spl_id": "59f6b9f3-3f6d-44c4-a7f3-29fe49cf97bc", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["R16CO5Y76E", "3G6A5W338E"], "rxcui": ["994435"], "spl_set_id": ["386f7a6c-4bfc-4140-a67b-07f6b520d58f"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Reese Pharmaceutical Co"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "18 PACKET in 1 CARTON (10956-501-18)  / 1 POWDER in 1 PACKET", "package_ndc": "10956-501-18", "marketing_start_date": "20200722"}, {"sample": false, "description": "24 PACKET in 1 CARTON (10956-501-24)  / 1 POWDER in 1 PACKET", "package_ndc": "10956-501-24", "marketing_start_date": "20200722"}, {"sample": false, "description": "50 PACKET in 1 CARTON (10956-501-50)  / 1 POWDER in 1 PACKET", "package_ndc": "10956-501-50", "marketing_start_date": "20200722"}], "brand_name": "Reese Headache Powders", "product_id": "10956-501_59f6b9f3-3f6d-44c4-a7f3-29fe49cf97bc", "dosage_form": "POWDER", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "10956-501", "generic_name": "Aspirin and Caffeine", "labeler_name": "Reese Pharmaceutical Co", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Reese Headache Powders", "active_ingredients": [{"name": "ASPIRIN", "strength": "845 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20200722", "listing_expiration_date": "20261231"}